Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013–2017
Supporting Files
Public Domain
-
Oct 2020
-
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:Shimbashi, Reiko ; Suzuki, Motoi ; Chang, Bin ; Watanabe, Hiroshi ; Tanabe, Yoshinari ; Kuronuma, Koji ; Oshima, Kengo ; Maruyama, Takaya ; Takeda, Hiroaki ; Kasahara, Kei ; Fujita, Jiro ; Nishi, Junichiro ; Kubota, Tetsuya ; Tanaka-Taya, Keiko ; Matsui, Tamano ; Sunagawa, Tomimasa ; Oishi, Kazunori
-
Corporate Authors:
-
Description:The decline in the proportion of pneumococcal conjugate vaccine (PCV)-covered serotypes among adult invasive pneumococcal disease (IPD) patients might change the overall effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) because its effectiveness differs according to serotype. Using the indirect cohort method, we calculated the effectiveness of PPSV23 against IPD among adults in Japan to assess the impact of the national pediatric PCV program. Clinical and epidemiologic information and pneumococcal isolates were collected from IPD patients >20 years of age through enhanced IPD surveillance during April 2013-December 2017. Adjusted effectiveness against PPSV23-serotype IPD was 42.2%. Despite a substantial decline in the proportion of 13-valent PCV serotypes during the study period (45% to 31%), the change in effectiveness for PPSV23-serotype IPD was limited (47.1% to 39.3%) and only marginal in the elderly population (39.9% to 39.4%). The pediatric PCV program had limited impact on PPSV23 effectiveness against IPD in adults.
-
Subjects:
-
Source:Emerg Infect Dis. 26(10):2378-2386
-
Pubmed ID:32946721
-
Pubmed Central ID:PMC7510723
-
Document Type:
-
Place as Subject:
-
Location:
-
Volume:26
-
Issue:10
-
Collection(s):
-
Main Document Checksum:urn:sha256:36ce583e91568aadcdedbc8da2dcb6e49cb2b396d0abec3cfa4ed1a71ee7dfe8
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases